Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wendy Stevens

Showing results (91-100 of 295) with videos related to

Pageof 30
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|July 15, 2022
Evaluation Protocol for SARS-CoV-2 Serological AssaysMaemu P Gededzha, Sarika Jugwanth, Nakampe Mampeule, et al.
American Journal of Respiratory and Critical Care Medicine|May 3, 2014
Xpert MTB/RIF as a measure of sputum bacillary burden. Variation by HIV status and immunosuppressionColleen F Hanrahan, Grant Theron, Jean Bassett, et al.
Journal of Scleroderma and Related Disorders|October 9, 2024
N-terminal pro-brain natriuretic peptide is associated with pulmonary hypertension or diastolic dysfunction in patients with systemic sclerosis: An Australian prospective cross-sectional studyFrancis J Ha, Zoe Brown, Wendy Stevens, et al.
Plos One|September 18, 2012
The implementation and appraisal of a novel confirmatory HIV-1 testing algorithm in the Microbicides Development Programme 301 Trial (MDP301)Ute Jentsch, Precious Lunga, Charles Lacey, et al.
Medicine|January 10, 2018
Quantifying the direct public health care cost of systemic sclerosis: A comprehensive data linkage studyKathleen Morrisroe, Wendy Stevens, Joanne Sahhar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 6, 2014
Drug susceptibility and resistance mutations after first-line failure in resource limited settingsCarole L Wallis, Evgenia Aga, Heather Ribaudo, et al.
Plos One|June 14, 2012
The impact and cost of scaling up GeneXpert MTB/RIF in South AfricaGesine Meyer-Rath, Kathryn Schnippel, Lawrence Long, et al.
BMC Medicine|July 26, 2015
A meta-analysis of the performance of the Pima™ CD4 for point of care testingLesley E Scott, Jennifer Campbell, Larry Westerman, et al.
The Journal of Biological Chemistry|June 12, 2010
Stabilization of HIV-1 gp120-CD4 receptor complex through targeted interchain disulfide exchangeNichole Cerutti, Barry V Mendelow, Grant B Napier, et al.
Clinical Rheumatology|April 25, 2018
Increased serum levels of adhesion molecules ICAM-1 and VCAM-1 in systemic sclerosis are not specific for pulmonary manifestationsVivek Thakkar, Karen A Patterson, Wendy Stevens, et al.
Pageof 30

Showing results (91-100 of 295) with videos related to

Sort By:
Pageof 30
Methods in Molecular Biology (Clifton, N.J.)|July 15, 2022
Evaluation Protocol for SARS-CoV-2 Serological AssaysMaemu P Gededzha, Sarika Jugwanth, Nakampe Mampeule, et al.
American Journal of Respiratory and Critical Care Medicine|May 3, 2014
Xpert MTB/RIF as a measure of sputum bacillary burden. Variation by HIV status and immunosuppressionColleen F Hanrahan, Grant Theron, Jean Bassett, et al.
Journal of Scleroderma and Related Disorders|October 9, 2024
N-terminal pro-brain natriuretic peptide is associated with pulmonary hypertension or diastolic dysfunction in patients with systemic sclerosis: An Australian prospective cross-sectional studyFrancis J Ha, Zoe Brown, Wendy Stevens, et al.
Plos One|September 18, 2012
The implementation and appraisal of a novel confirmatory HIV-1 testing algorithm in the Microbicides Development Programme 301 Trial (MDP301)Ute Jentsch, Precious Lunga, Charles Lacey, et al.
Medicine|January 10, 2018
Quantifying the direct public health care cost of systemic sclerosis: A comprehensive data linkage studyKathleen Morrisroe, Wendy Stevens, Joanne Sahhar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 6, 2014
Drug susceptibility and resistance mutations after first-line failure in resource limited settingsCarole L Wallis, Evgenia Aga, Heather Ribaudo, et al.
Plos One|June 14, 2012
The impact and cost of scaling up GeneXpert MTB/RIF in South AfricaGesine Meyer-Rath, Kathryn Schnippel, Lawrence Long, et al.
BMC Medicine|July 26, 2015
A meta-analysis of the performance of the Pima™ CD4 for point of care testingLesley E Scott, Jennifer Campbell, Larry Westerman, et al.
The Journal of Biological Chemistry|June 12, 2010
Stabilization of HIV-1 gp120-CD4 receptor complex through targeted interchain disulfide exchangeNichole Cerutti, Barry V Mendelow, Grant B Napier, et al.
Clinical Rheumatology|April 25, 2018
Increased serum levels of adhesion molecules ICAM-1 and VCAM-1 in systemic sclerosis are not specific for pulmonary manifestationsVivek Thakkar, Karen A Patterson, Wendy Stevens, et al.
Pageof 30